Abstract

BackgroundTo identify the prognostic factors for survival in patients with interstitial pneumonia with autoimmune features (IPAF) who meet the serological domain of the IPAF criteria.MethodsWe retrospectively analysed 99 IPAF patients who met the serological domain and were hospitalised at the Respiratory Medicine Unit of Kurashiki Central Hospital from 1999 to 2015. The high-resolution computed tomography findings were usual interstitial pneumonia (UIP; n = 1), non-specific interstitial pneumonia (NSIP; n = 63), NSIP with organizing pneumonia (OP) overlap (n = 15), and OP (n = 20). One patient who had radiological UIP pattern, and met the serological and clinical domains was excluded. The clinical characteristics, radiological findings, administered therapy, and prognosis of the remaining 98 IPAF patients who met the serological and morphological domains were analysed.ResultsThe median age of the 98 IPAF patients was 68 years, and 41 (41.8%) of them were men. Twelve (12.2%) of the 98 IPAF patients developed other characteristics and were diagnosed with connective tissue disease (CTD) later during the median follow-up of 4.5 years. Univariate Cox analysis revealed systemic sclerosis (SSc)-specific and SSc-associated antibodies (ANA nucleolar pattern, ANA centromere pattern, anti-ribonucleoprotein and anti-Scl-70) positive IPAF, radiological NSIP pattern, bronchoalveolar lavage fluid lymphocytes >15%, and age as significant prognostic factors for survival. Multivariate Cox analysis revealed radiological NSIP pattern (hazard ratio [HR], 4.48; 95% confidence interval [CI], 1.28–15.77, p = 0.02) and age (HR, 1.07; 95% CI, 1.02–1.11, p = 0.01) were significantly associated with worse survival.ConclusionsWe confirmed that radiological NSIP pattern and age are poor prognostic factors for the survival of IPAF patients. This study suggested that the autoantibodies that are highly specific for certain connective tissue diseases might be less important for the prognosis of IPAF compared with the radiological-pathological patterns. The relatively high proportion of IPAF patients who developed CTD later suggests the importance of careful observation for evolution to CTD in IPAF.

Highlights

  • To identify the prognostic factors for survival in patients with interstitial pneumonia with autoimmune features (IPAF) who meet the serological domain of the IPAF criteria

  • If IPAF is thought to be a lungdominant variant of connective tissue disease (CTD) or a CTD preceded by interstitial pneumonia, does the prognosis of IPAF patients differ according to the antibodies that are highly specific for certain CTDs?

  • Radiological, and physiological characteristics of study participants stratified according to High-resolution computed tomography (HRCT) Of the 98 IPAF patients, 20 (20.4%) were radiologically classified as organizing pneumonia (OP), 15 (15.3%) as non-specific interstitial pneumonia (NSIP) + OP, and 63 (64.3%) as NSIP

Read more

Summary

Introduction

To identify the prognostic factors for survival in patients with interstitial pneumonia with autoimmune features (IPAF) who meet the serological domain of the IPAF criteria. Many patients with idiopathic interstitial pneumonia (IIP) present clinical features that suggest an underlying autoimmune process but do not meet the established criteria for connective tissue disease (CTD). In IIP patients, survival and prognosis differ according to the histological pattern, baseline pulmonary function, and age [1,2,3,4]. For patients with CTD-associated interstitial lung disease (ILD), the effect of histological pattern on survival is less certain [5,6,7]. If IPAF is thought to be a lungdominant variant of CTD or a CTD preceded by interstitial pneumonia, does the prognosis of IPAF patients differ according to the antibodies that are highly specific for certain CTDs?

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.